Preparation of 16β-Estradiol Derivative Libraries as Bisubstrate Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 Using the Multidetachable Sulfamate Linker

被引:9
|
作者
Berube, Marie
Delagoutte, Florian
Poirier, Donald [1 ]
机构
[1] CHU Laval, Res Ctr, CHUQ, Med Chem Lab, Quebec City, PQ G1V 4G2, Canada
来源
MOLECULES | 2010年 / 15卷 / 03期
基金
加拿大自然科学与工程研究理事会; 加拿大健康研究院;
关键词
Solid-phase synthesis; sulfamate linker; steroid; inhibitor; 17; beta-HSD; ESTRADIOL-ADENOSINE HYBRIDS; CHEMICAL-SYNTHESIS; BIOLOGICAL EVALUATION; POTENT INHIBITORS; ESTRONE; DESIGN; BREAST; CANCER; DEHYDROGENASE; STEROIDS;
D O I
10.3390/molecules15031590
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Combinatorial chemistry is a powerful tool used to rapidly generate a large number of potentially biologically active compounds. In our goal to develop bisubstrate inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 (17 beta-HSD1) that interact with both the substrate (estrone or estradiol) and the cofactor (NAD(P) H) binding sites, we used parallel solid-phase synthesis to prepare three libraries of 16 beta-estradiol derivatives with two or three levels of molecular diversity. From estrone, we first synthesized a sulfamate precursor that we loaded on trityl chloride resin using the efficient multidetachable sulfamate linker strategy recently developed in our laboratory. We then introduced molecular diversity [one or two amino acid(s) followed by a carboxylic acid] on steroid nucleus by Fmoc peptide chemistry. Finally, after a nucleophilic cleavage, libraries of 30, 63 and 25 estradiol derivatives were provided. A library of 30 sulfamoylated estradiol derivatives was also generated by acidic cleavage and its members were screened for inhibition of steroid sulfatase. Biological evaluation on homogenated HEK-293 cells overexpressing 17 beta-HSD1 of the estradiol derivatives carrying different oligoamide-type chains at C-16 first revealed that three levels of molecular diversity (a spacer of two amino acids) were necessary to interact with the adenosine part of the cofactor binding site. Second, the best inhibition was obtained when hydrophobic residues (phenylalanine) were used as building blocks.
引用
收藏
页码:1590 / 1631
页数:42
相关论文
共 50 条
  • [31] Discovery of nonsteroidal 17β-hydroxysteroid dehydrogenase 1 inhibitors by pharmacophore-based screening of virtual compound libraries
    Schuster, Daniela
    Nashev, Lyubomir G.
    Kirchmair, Johannes
    Laggner, Christian
    Wolber, Gerhard
    Langer, Thierry
    Odermatt, Alex
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (14) : 4188 - 4199
  • [32] Bicyclic Substituted Hydroxyphenylmethanone Type Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1): The Role of the Bicyclic Moiety
    Oster, Alexander
    Klein, Tobias
    Henn, Claudia
    Werth, Ruth
    Marchais-Oberwinkler, Sandrine
    Frotscher, Martin
    Hartmann, Rolf W.
    CHEMMEDCHEM, 2011, 6 (03) : 476 - 487
  • [33] Preparation of two steroid derivatives and its theoretical interaction with a 17β-hydroxysteroid dehydrogenase type 1
    Lauro, Figueroa-Valverde
    Abelardo, Camacho-Luis
    Francisco, Diaz-Cedillo
    Marcela, Rosas-Nexticapa
    Virginia, Mateu-Armand
    Patricia, Hernandez-Vasquez
    Eduardo, Pool-Gomez
    Maria, Lopez-Ramos
    Lenin, Hau-Heredia
    Tomas Joel, Lopez-Gutierrez
    Bety, Sarabia-Alcocer
    Alondra, Alfonso-Jimenez
    Jhair, Cabrera-Tuz
    BIOINTERFACE RESEARCH IN APPLIED CHEMISTRY, 2019, 9 (01): : 3800 - 3805
  • [34] E-ring modified steroids as novel potent inhibitors of 17β-hydroxysteroid dehydrogenase type 1
    Fischer, DS
    Allan, GM
    Bubert, C
    Vicker, N
    Smith, A
    Tutill, HJ
    Purohit, A
    Wood, L
    Packham, G
    Mahon, MF
    Reed, MJ
    Potter, BVL
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5749 - 5770
  • [35] Inhibitors of 17β-hydroxysteroid dehydrogenase type 1, 2 and 14: Structures, biological activities and future challenges
    Salah, Mohamed
    Abdelsamie, Ahmed S.
    Frotscher, Martin
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2019, 489 : 66 - 81
  • [36] Synthesis and evaluation of estradiol derivatives with 16 alpha-(bromoalkylamide), 16 alpha-(bromoalkyl) or 16 alpha-(bromoalkynyl) side chain as inhibitors of 17 beta-hydroxysteroid dehydrogenase type 1 without estrogenic activity
    Pelletier, JD
    Poirier, D
    BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (10) : 1617 - 1628
  • [37] Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1
    Aka, Juliette A.
    Calvo, Ezequiel-Luis
    Lin, Sheng-Xiang
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2017, 439 (0C) : 175 - 186
  • [38] Estrone C15 derivatives-A new class of 17β-hydroxysteroid dehydrogenase type 1 inhibitors
    Messinger, Josef
    Husen, Bettina
    Koskimies, Pasi
    Hirvela, Leena
    Kallio, Lila
    Saarenketo, Pauli
    Thole, Hubert
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 301 (1-2) : 216 - 224
  • [39] SYNTHESIS OF 16-(BROMOALKYL)-ESTRADIOLS HAVING INHIBITORY EFFECT ON HUMAN PLACENTAL ESTRADIOL 17-BETA-HYDROXYSTEROID DEHYDROGENASE (17-BETA-HSD TYPE-1)
    TREMBLAY, MR
    AUGER, S
    POIRIER, D
    BIOORGANIC & MEDICINAL CHEMISTRY, 1995, 3 (05) : 505 - 523
  • [40] 17-β-hydroxysteroid dehydrogenase type 1:: computational design of active site inhibitors targeted to the Rossmann fold
    Brown, WM
    Metzger, LE
    Barlow, JP
    Hunsaker, LA
    Deck, LM
    Royer, RE
    Vander Jagt, DL
    CHEMICO-BIOLOGICAL INTERACTIONS, 2003, 143 : 481 - 491